M. Cremonesi

910 total citations
19 papers, 344 citations indexed

About

M. Cremonesi is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, M. Cremonesi has authored 19 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in M. Cremonesi's work include Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). M. Cremonesi is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). M. Cremonesi collaborates with scholars based in Italy, Germany and Netherlands. M. Cremonesi's co-authors include Sandro Barni, Mario Mandalà, Marinos Kallikourdis, Marina Elena Cazzaniga, Mary Cabiddu, Roberto Labianca, Giulia Veronesi, Elisa Dama, Tommaso Colangelo and Fabrizio Bianchi and has published in prestigious journals such as Circulation, Neuron and Journal of Clinical Oncology.

In The Last Decade

M. Cremonesi

19 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Cremonesi Italy 10 85 83 72 59 58 19 344
Milena Świtońska Poland 9 54 0.6× 51 0.6× 38 0.5× 35 0.6× 28 0.5× 17 285
Peter J. Thurlow Australia 13 39 0.5× 67 0.8× 48 0.7× 54 0.9× 131 2.3× 33 397
Caroline J. Reddel Australia 13 35 0.4× 91 1.1× 137 1.9× 159 2.7× 91 1.6× 18 399
Thomas Wurster Germany 13 37 0.4× 46 0.6× 20 0.3× 149 2.5× 57 1.0× 29 375
Eric E. Fox Canada 2 46 0.5× 49 0.6× 146 2.0× 57 1.0× 78 1.3× 2 309
Kohsuke Yamashita Japan 14 36 0.4× 91 1.1× 21 0.3× 54 0.9× 27 0.5× 33 487
Grace Monori United Kingdom 8 75 0.9× 123 1.5× 10 0.1× 41 0.7× 74 1.3× 9 422
Sayaka Moriguchi‐Goto Japan 14 19 0.2× 80 1.0× 94 1.3× 105 1.8× 121 2.1× 24 410
Tetsunori Ishikawa Japan 12 45 0.5× 54 0.7× 20 0.3× 221 3.7× 46 0.8× 34 451
Daniela Cugino Italy 7 78 0.9× 55 0.7× 30 0.4× 66 1.1× 32 0.6× 8 272

Countries citing papers authored by M. Cremonesi

Since Specialization
Citations

This map shows the geographic impact of M. Cremonesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Cremonesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Cremonesi more than expected).

Fields of papers citing papers by M. Cremonesi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Cremonesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Cremonesi. The network helps show where M. Cremonesi may publish in the future.

Co-authorship network of co-authors of M. Cremonesi

This figure shows the co-authorship network connecting the top 25 collaborators of M. Cremonesi. A scholar is included among the top collaborators of M. Cremonesi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Cremonesi. M. Cremonesi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mancinelli, Sara, Antonella Borreca, M. Cremonesi, et al.. (2025). Neurodevelopmental origins of structural and psychomotor defects in CXCR4-linked primary immunodeficiency. Neuron. 113(16). 2636–2655.e9. 1 indexed citations
2.
Panico, Cristina, Paolo Kunderfranco, M. Cremonesi, et al.. (2023). Single-Cell RNA Sequencing Reveals Metabolic Stress-Dependent Activation of Cardiac Macrophages in a Model of Dyslipidemia-Induced Diastolic Dysfunction. Circulation. 150(19). 1517–1532. 29 indexed citations
3.
Burrello, Claudia, Francesco Strati, Georgia Lattanzi, et al.. (2022). IL10 Secretion Endows Intestinal Human iNKT Cells with Regulatory Functions Towards Pathogenic T Lymphocytes. Journal of Crohn s and Colitis. 16(9). 1461–1474. 12 indexed citations
4.
Dama, Elisa, Tommaso Colangelo, M. Cremonesi, et al.. (2021). Biomarkers and Lung Cancer Early Detection: State of the Art. Cancers. 13(15). 3919–3919. 55 indexed citations
5.
Bonacina, Fabrizia, Elisa Martini, Monika Svecla, et al.. (2020). Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression. Cardiovascular Research. 117(9). 2069–2082. 31 indexed citations
6.
Bonacina, Fabrizia, Elisa Martini, Stefano Garetto, et al.. (2019). Engineered Regulatory T Cell Adoptive Therapy As A Novel Tool For The Treatment Of Atherosclerosis. Atherosclerosis. 287. e18–e18. 1 indexed citations
7.
Conti, Antonio, M. Cremonesi, Patrizia D’Adamo, et al.. (2017). Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia. EMBO Molecular Medicine. 10(1). 91–106. 41 indexed citations
8.
Petrelli, Fausto, Andrea Coinu, Karen Borgonovo, et al.. (2014). Resection Rate with Folfirinox-Based Neoadjuvant Therapy in Locally Advanced/Borderline Resectable Pancreatic Cancer: a Pooled Analysis of Published Data. Annals of Oncology. 25. iv240–iv240. 2 indexed citations
9.
Barni, Sandro, Andrea Coinu, Karen Borgonovo, et al.. (2014). Cisplatin versus cetuximab plus concomitant radiotherapy in locally advanced head and neck cancer: A meta-analysis of published trials.. Journal of Clinical Oncology. 32(15_suppl). 6014–6014. 6 indexed citations
10.
Petrelli, Fausto, Mara Ghilardi, M. Cremonesi, Mary Cabiddu, & Sandro Barni. (2009). Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue. Expert Review of Anticancer Therapy. 9(10). 1455–1465. 1 indexed citations
11.
Mandalà, Mario, Sandro Barni, Martin H. Prins, et al.. (2009). Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Annals of Oncology. 21(4). 871–876. 79 indexed citations
12.
Petrelli, Fausto, Mary Cabiddu, Marina Elena Cazzaniga, M. Cremonesi, & Sandro Barni. (2008). Targeted Therapies for the Treatment of Breast Cancer in the Post-trastuzumab Era. The Oncologist. 13(4). 373–381. 22 indexed citations
13.
Barni, Sandro, Fausto Petrelli, Mary Cabiddu, Marina Elena Cazzaniga, & M. Cremonesi. (2007). From the trastuzumab era to new target therapies: beyond revolution. Annals of Oncology. 18. vi1–vi4. 8 indexed citations
14.
Barni, Sandro, Mario Mandalà, Marina Elena Cazzaniga, Mary Cabiddu, & M. Cremonesi. (2006). Bisphosphonates and metastatic bone disease. Annals of Oncology. 17. ii91–ii95. 13 indexed citations
15.
Mandalà, Mario, et al.. (2006). Optimizing use of opiates in the management of cancer pain. Therapeutics and Clinical Risk Management. 2(4). 447–453. 17 indexed citations
16.
Mandalà, Mario, M. Cremonesi, Andrea Rocca, et al.. (2005). Midazolam for acute emesis refractory to dexamethasone and granisetron after highly emetogenic chemotherapy: a phase II study. Supportive Care in Cancer. 13(6). 375–380. 13 indexed citations
17.
Nisticò, Cecilia, A. De Matteis, Emanuela Rossi, et al.. (2005). Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer.. PubMed. 25(2B). 1343–8. 7 indexed citations
18.
Cremonesi, M., et al.. (2003). Vinorelbine and Carboplatin in Inoperable Non-Small Cell Lung Cancer: A Monoinstitutional Phase II Study. Oncology. 64(2). 97–101. 3 indexed citations
19.
Nisticò, Cecilia, A. De Matteis, Roberto Valenza, et al.. (1998). P71 Epirubicin (EPI) and vinorelbine (VNR): A new promising combination for primary systemic chemotherapy for breast cancer. European Journal of Cancer. 34. S33–S33. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milena Świtońska Breakdown of academic impact, for papers by Peter J. Thurlow Breakdown of academic impact, for papers by Caroline J. Reddel Breakdown of academic impact, for papers by Thomas Wurster Breakdown of academic impact, for papers by Eric E. Fox Breakdown of academic impact, for papers by Kohsuke Yamashita Breakdown of academic impact, for papers by Grace Monori Breakdown of academic impact, for papers by Sayaka Moriguchi‐Goto Breakdown of academic impact, for papers by Tetsunori Ishikawa Breakdown of academic impact, for papers by Daniela Cugino
Rankless by CCL
2026